Open Access

Transcriptome analysis of chicken kidney tissues following coronavirus avian infectious bronchitis virus infection

  • Feng Cong1,
  • Xiaoli Liu1,
  • Zongxi Han1,
  • Yuhao Shao1,
  • Xiangang Kong1 and
  • Shengwang Liu1Email author
BMC Genomics201314:743

DOI: 10.1186/1471-2164-14-743

Received: 23 April 2013

Accepted: 26 October 2013

Published: 30 October 2013

Abstract

Background

Infectious bronchitis virus (IBV), a prototype of the Coronaviridae family, is an economically important causative agent of infectious bronchitis in chickens and causes an acute and highly contagious upper respiratory tract infections that may lead to nephritis. However, the molecular antiviral mechanisms of chickens to IBV infection remain poorly understood. In this study, we conducted global gene expression profiling of chicken kidney tissue after nephropathogenic IBV infection to better understand the interactions between host and virus.

Results

IBV infection contributed to differential expression of 1777 genes, of which 876 were up-regulated and 901 down-regulated in the kidney compared to those of control chickens and 103 associated with immune and inflammatory responses may play important roles in the host defense response during IBV infection. Twelve of the altered immune-related genes were confirmed by real-time RT-PCR. Gene ontology category, KEGG pathway, and gene interaction networks (STRING analysis) were analyzed to identify relationships among differentially expressed genes involved in signal transduction, cell adhesion, immune responses, apoptosis regulation, positive regulation of the I-kappaB kinase/NF-kappaB cascade and response to cytokine stimulus. Most of these genes were related and formed a large network, in which IL6, STAT1, MYD88, IRF1 and NFKB2 were key genes.

Conclusions

Our results provided comprehensive knowledge regarding the host transcriptional response to IBV infection in chicken kidney tissues, thereby providing insight into IBV pathogenesis, particularly the involvement of innate immune pathway genes associated with IBV infection.

Keywords

Infectious bronchitis virus Kidney Microarray Transcriptome

Background

Avian infectious bronchitis virus (IBV) is a gamma coronavirus in the family Coronaviridae, which has been identified as the causative agent of infectious bronchitis (IB) as well as serious acute viral respiratory and urogenital diseases in commercial chickens flocks worldwide [1, 2]. Infected chickens develop respiratory symptoms, kidney and oviduct lesions, reduced egg production with poor egg quality, and possible secondary complications [3, 4]. IBV can replicate within the epithelial surfaces of the kidneys and cause granular degeneration, vacuolation, and desquamation of the tubular epithelium, and massive infiltration of heterophils in the interstitium. IBV-induced kidney lesions are typically characterized by interstitial nephritis and tubule lesions that are most prominent in the medulla [5, 6].

Interactions between viruses and hosts occur at two levels: viral capacity to gain access to the target cell and competition between the viruses and host cells to control the cellular protein synthesis machinery. The virus/host interactions are largely determined by the virulence of the pathogen and the host immune response [7], and may lead to changes in host gene expression. However, many aspects of IBV-host interactions remain unclear. Elucidation of the basis of the interactions between IBV and kidney cells will provide new insights into the immune mechanisms underlying host antiviral strategies and the pathogenesis of viral infection. To date, a limited number of studies have examined host gene expression in response to IBV infection on a relatively large scale using microarrays or two-dimensional gel electrophoresis [8, 9]. Gene expression alterations in avian embryonic tissues infected with IBV isolate B8358 were evaluated using a microarray containing 1191 unique chicken and turkey gene transcripts. Regulated expression has been established with several functional gene classes and pathways, including those coding kinases, interferon (IFN)-induced genes, chemokines, adhesins, vesicular trafficking and fusion proteins genes, extracellular matrix protein genes, the cell cycle, cell metabolism, physiology, and development, translation, RNA binding, lysosomal protein degradation and ubiquitination-related genes [10]. In addition, the gene transcription profiles of tracheal epithelial cells were examined 3 days postinfection with an attenuated IBV-Massachusetts strain [11]. These authors investigated 25 direct immune-related genes and found an up-regulation in toll-like receptor (TLR)2, TLR3, IFN-induced antiviral genes (Mx), and genes responsible for cytotoxic T cell killing, such as the Fas antigen and granzyme-A. More recently, changes in ex vivo and in ovo protein expression in Vero cells as well as chicken trachea and kidney tissues were reported after IBV infection [8, 9, 12, 13]. However, there is limited information available regarding transcriptomics of host kidney cells in response to IBV infection. The current study was designed to compare the transcriptomes of kidney cells in IBV-infected chickens to those of control chickens. A subset of genes of interest identified by microarray analysis was validated by quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR). The putative importance of some of these genes in IBV pathogenesis and immune response were also analyzed. The global gene expression profiling of chicken kidney tissue after nephropathogenic IBV infection will enable a better understanding of the pathogenesis of IBV infection and extend the knowledge of the nature of virus-host interactions.

Methods

Animals, viral infection and detection in kidney

One-day-old specific pathogen-free (SPF) chickens were obtained from the Laboratory Animal Center, Harbin Veterinary Research Institute, the Chinese Academy of Agricultural Sciences (Harbin, China). All animal experimental procedures were approved by the Ethical and Animal Welfare Committee of Heilongjiang Province, China.

Twenty 1-day-old SPF White Leghorn chicks were housed in separate isolators and divided into two groups of 10 chicks each. Each chick in group 1 was intranasally inoculated with 0.1 mL of 105.5 median embryo infectious doses of strain ck/CH/LDL/091022 [14] at 15 days of age. Chicks in group 2 served as virus-free controls. Two birds in group 1 died at 5 and 6 days postinoculation (dpi), respectively, and fresh tissue samples of kidney from each dead bird were collected at the time of death. The kidneys from one bird in the control group were also collected at each time point corresponding to the bird deaths and then stored at-80°C until further processed. Serum samples were collected at 12 days dpi from the remaining group 1 and control birds and assayed in triplicate using a commercial total antibody enzyme-linked immunosorbent assay (IDEXX Laboratories, Inc., Westbrook, MA, USA) according to the manufacturer’s instructions. Serum-to-positive ratios were calculated as described previously [15]. Individual serum titers were expressed as absorption values at an optical density at 630 nm according to the manufacturer’s instructions. Real-time RT-PCR was used to quantify viral load in the kidneys of two dead IBV-infected chickens as described previously [16]. The remaining birds in both groups were killed humanely 15 dpi and kidney tissues were collected for virus recovery as described previously [15].

RNA extraction, reverse transcription, RNA labeling, and cRNA hybridization

Total RNA was extracted from kidneys of uninfected birds or those that died from IBV infection using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) and then purified using the QiagenRNeasy Mini Kit (Qiagen, Valencia, CA, USA) according to the manufacturer’s instructions. RNA was quantified and qualified using the Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA). Briefly, 2 μg of total RNA were converted to cDNA, synthesized to Cy3-labelled cRNA, and amplified for one round using a commercial array service (Agilent Technologies, America). The Cy3-labeled cRNA probes were hybridized to a 4 × 44 K Agilent custom chicken oligo microarray (design ID: 017698). Scanning of the arrays was performed according to standard protocols using a G2505C Scanner (Agilent Technologies).

Microarray analysis

Microarray data were subjected to bioinformatic analysis to identify statistically significant changes in gene expression between samples using GeneSpring GX 11.0 software (Agilent Technologies). Annotations for the microarray genes were downloaded from the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/), the Gene Ontology (GO) (http://www.geneontology.org/), and UniProt (http://www.uniprot.org/) databases. The GO category (http://www.geneontology.org) based on biological process and KEGG (http://www.genome.jp/kegg/) pathway analysis was determined for differentially expressed genes and a probability (p)-value < 0.05 and a false discovery rate (FDR) < 0.05 was used as a threshold. Gene interaction networks were analyzed using the STRING (http://string-db.org/) database of known and predicted protein interactions, which included direct (physical) and indirect (functional) associations.

Real-time RT-PCR for confirmation

Twelve genes of interest were selected for confirmation with 18S serving as an endogenous control. Specific primers and probes were designed using Beacon Designer software 7.5 (Premier Biosoft International, Palo Alto, CA, USA). The primers and probes used for the RT-PCR assays are listed in Table 1. Total RNA was extracted using TRIzol Reagent (TaKaRa Biotech Co., Ltd., Dalian, China) according to the manufacturer’s instructions. One-step real-time RT-PCR reactions were performed using the One Step PrimeScript® RT-PCR kit (TaKaRa Biotech Co., Ltd.) on the Light-Cycler® 480 real-time PCR system (Roche Diagnostics, Basel, Switzerland) according to the following steps: reverse transcription at 42°C for 10 min, denaturation at 95°C for 10 s and 40 cycles at 95°C for 5 s, 55°C for 20 s, and 72°C for 10 s, followed by a cooling step at 40°C for 10 s. All samples were assayed in triplicate in each reaction. The data were analyzed using the standard curve method available with the LightCycler® 480 Software ver. 1.5.
Table 1

Primers and probes used for the RT-PCR assays

Gene

GenBank ID

Forward primers (5′-3′)

Probes (5′-3′)

Reverse primers (5′-3′)

STAT1

NM_001012914

AAGCAAACGTAATCTTCAGGATAAC

(FAM)-CAAGAAGACCCGATACACATGGCAA-(BHQ1)

TTTCTCTCCTCTTTCAGACAGTTG

ISG12-2

NM_001001296

TTCCACTATCCAGTCTATCTCAATG

(FAM)-ACCTGCTCCTGGACCGATGCTTCTT-(BHQ1)

GTGAATCTGTCTGTAAAGGATGAAC

SOCS3

NM_204600

ACTGCGCCCCAGGTGATG

(FAM)-CTCCCGGCAGCAGCACCCC-(BHQ1)

GGGAACTTGCTGTGGGTGAC

TNFAIP6

NM_001037837

GAGGCAGCGAGAAAAATAGGTTTC

(FAM)-CCATCCAGCCAGCAGCACACAC-(BHQ1)

GCTTTTACTATGGGGTAACCAACTC

IRG1

NM_001030821

TCCGAGATGTGGGCAAAGAC

(FAM)-TCGCTTGCTTCTCTGAATGACCACA-(BHQ1)

CCTACTCCAAGGGTATCCAGAATC

SPP1

NM_204535

CCAGAACAGCCGGACTTTC

(FAM)-TGACATTCCTAGCAAGAGCCAAGAG-(BHQ1)

TGGAATCATTGTCATCATCATCATC

18S

FM165414

GGTTGCAAAGCTGAAACTTAAAGG

(FAM)-ACTCCTGGTGGTGCCCTTCCGTCAA-(BHQ1)

TGAGGTTTCCCGTGTTGAGTC

IFIT5

XM_421662

AAAAGAAGGCAAATCATGAGTACC

(FAM)-AATTCCTTGAAGAACTCCCTGCTGC-(BHQ1)

TGATCCTCTATTGATTCTTCCAGAC

MX1

NM_204609

AGAAAGCAATAAGAAAAGCCCAAG

(FAM)-AATGCTACCATTAGTGCCAGCCAC-(BHQ1)

ACCAGATTTCAAGGGAAATTAGTTC

OASL

NM_205041

AGCACTGGTACAAGGAGATGTTG

(FAM)-CTGAAGTCCTCCCTGCCTGTGCCCT-(BHQ1)

CCAAGCAGCTCCAGCACAG

RSAD2

XM_426208

CTTAAGGAGGCGGGAATGGAG

(FAM)-TTGCTCACAATGCTGACGCTTGGC-(BHQ1)

TTGAACCACCGTTCCCTGATC

Results

Clinical observations, serology, and IBV detection in kidney tissues

The chicks inoculated with strain ck/CH/LDL/091022 showed clinical signs from dpi 3 to 13. The diseased chicks were listless, huddled together, and displayed ruffled feathers and dark, shrunken combs. Two chicks died during the experiment and experienced obvious swelling and loss of blood to the kidneys, as well as distended tubules and ureters with urates, suggesting that ck/CH/LDL/091022 was nephropathogenic (Figure 1) [14]. The clinical signs of the inoculated birds tended to gradually disappear after 13 dpi. No obvious clinical signs were observed in the uninfected control chickens during the experiment.
https://static-content.springer.com/image/art%3A10.1186%2F1471-2164-14-743/MediaObjects/12864_2013_Article_5452_Fig1_HTML.jpg
Figure 1

Renal lesions associated with IB caused by IBV strain ck/CH/LDL/091022. Note swollen kidneys with tubules and ureters distended with urates.

All chickens inoculated with strain ck/CH/LDL/091022 showed a positive serum antibody response at 12 dpi, whereas those in the control group showed a negative serum antibody response. IBV infection was also verified using real-time RT-PCR. Kidney tissue samples from each dead bird had detectable viral RNA with 3.26 × 108 and 1.32 × 108 copies/mg viral RNA, respectively. Viruses were not detected in the kidney samples from the control group. In addition, IBV was recovered from the kidneys of 5 out of 8 chickens challenged with strain ck/CH/LDL/091022 at 15 dpi using 9-day-old embryos; however, virus were not recovered in the kidneys of the eight control birds. Collectively, these results confirmed successful IBV infection of SPF chicken and those used for transcriptome analysis that died from IBV infection.

Overview of differentially regulated genes after IBV infection

RNA from kidney tissues retrieved from the two chickens that died at 5 and 6 dpi, respectively, and two uninfected control chickens were extracted and analyzed individually using a microarray to compare gene expression profiles between the groups. Microarray analysis identified 1777 genes, which were differentially regulated more than three-fold in response to IBV infection. Among the differentially expressed (DE) genes, 876 were up-regulated and 901 down-regulated. The DE genes were classified into 98 functional groups (see Additional file 1) according to the GO project for biological processes and the top 12 biological process groups of the genes are shown in Figure 2. The main GO categories for the upregulated genes were immune response (e.g., interleukin (IL)6 and IFN regulatory factor (IRF) 8), positive apoptosis regulation (e.g., BCL2-antagonist/killer 1 and Fas), and negative apoptosis regulation (e.g., clusterin and microphthalmia-associated transcription factor), among others (Figure 2). The primary GO categories for the downregulated genes were response to cell adhesion (e.g., neuropilin 1 and contactin 1), signal transduction (e.g., endoglin and fibrinogen-like 2 ), and metabolic process (e.g., glutathione transferase and arylacetamidedeacetylase-like 4), among others (Figure 2). Particularly, the microarray results indicated that 103 genes associated with immune and inflammatory responses may play important roles in the host defense response during IBV infection (Table 2).
https://static-content.springer.com/image/art%3A10.1186%2F1471-2164-14-743/MediaObjects/12864_2013_Article_5452_Fig2_HTML.jpg
Figure 2

GO category based on biological processes for differentially expressed genes. The significant GO category for differentially expressed genes, the DE genes mainly clustered into 12 functional groups with varied numbers. p-value < 0.05 and FDR < 0.05 were used as a threshold to select significant GO categories. Exact p-value calculation for GO category in Additional file 1.

Table 2

DE genes associated with immune and inflammatory responses

Biological process

Gene symbol

Accession no

Gene description

Fold change

Innate immune response

MALT1

XM_413722

mucosa associated lymphoid tissue lymphoma translocation gene 1

+2.847583

CLU

NM_204900

clusterin

+9.196763

DMBT1

CR353989

deleted in malignant brain tumors 1

+2.036204

DUSP4

NM_204838

dual specificity phosphatase 4

+19.50851

DUSP6

NM_204354

dual specificity phosphatase 6

+2.1367393

DUSP10

NM_001031044

dual specificity phosphatase 10

+2.5124102

LY96

BX931181

lymphocyte antigen 96

+4.2568717

SAMHD1

NM_001030845

SAM domain and HD domain 1

+5.7296877

ERAP1

AJ851612

endoplasmic reticulum aminopeptidase 1

+5.731377

HMGB1

NM_204902

high mobility group box 1

+3.24355

TMEM173

CR354327

transmembrane protein 173

+9.81937

CFI

XM_426329

complement factor I

+5.3699164

IL1R1

NM_205485

interleukin 1 receptor, type I

+2.814695

IRAK2

NM_001030605

interleukin-1 receptor-associated kinase 2

+2.1085246

IRF7

NM_205372

interferon regulatory factor 7

+4.334887

JUN

NM_001031289

jun proto-oncogene

+3.481312

MAP3K14

NM_001030927

mitogen-activated protein kinase kinasekinase 14

+2.0599

MYD88

NM_001030962

myeloid differentiation primary response gene (88)

+2.0273855

NCF2

CR391316

neutrophil cytosolic factor 2

+9.767744

NFKB2

NM_204413

nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)

+4.372285

MASP1

NM_213586

mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor)

-5.984035

PELI1

NM_001012872

pellino homolog 1 (Drosophila)

-2.6004448

SIGIRR

NM_001199542

single immunoglobulin and toll-interleukin 1 receptor (TIR) domain

-3.878401

MRPS6

NM_001031486

mitochondrial ribosomal protein S6

-7.8250012

IFIH1

NM_001193638

interferon induced with helicase C domain 1

+11.25022

SRPK1

XM_419265

SFRS protein kinase 1

+2.4798062

TLR4

NM_001030693

toll-like receptor 4

+2.019901

TLR5

CR353090

toll-like receptor 5

-2.4051092

C1R

XM_416518

complement component 1, r subcomponent

+13.635473

C1S

NM_001030777

complement component 1, s subcomponent

+16.500757

C3

NM_205405

complement component 3

+25.31715

C4BPA

NM_204664

complement component 4 binding protein, alpha

-2.476029

C8B

BX934795

complement component 8, beta polypeptide

-2.8326783

TRIM25

XM_415653

tripartite motif-containing 25

+3.5009384

COLEC12

NM_001039599

collectin sub-family member 12

-11.011364

ITCH

XM_417330

itchy homolog E3 ubiquitin protein ligase (mouse)

+2.3843937

MARCO

NM_204736

macrophage receptor with collagenous structure

-3.0318317

FADD

XM_421073

Fas (TNFRSF6)-associated via death domain

-2.127713

IL18R1

NM_001145225

interleukin 18 receptor 1

+3.5603435

VNN1

NM_001039288

vanin 1

+30.900112

IL1RL1

NM_204275

interleukin 1 receptor-like 1

-9.989544

Cytokine-mediated signaling pathway

ADAR

AM179858

adenosine deaminase, RNA-specific

+2.2560015

USP18

CR354286

ubiquitin specific peptidase 18

+14.18105

EGR1

CR389000

early growth response 1

+4.516151

IRF8

NM_205416

interferon regulatory factor 8

+4.638908

IFI35

BX934680

interferon-induced protein 35

+4.3734093

IFNGR1

NM_001130387

interferon gamma receptor 1

+2.4954834

IL6

NM_204628

interleukin 6 (interferon, beta 2)

+75.02113

IL13RA2

NM_001048078

interleukin 13 receptor, alpha 2

+5.0171814

IRF1

NM_205415

interferon regulatory factor 1

+7.012157

IRF7

NM_205372

interferon regulatory factor 7

+4.334887

LIFR

NM_204575

leukemia inhibitory factor receptor alpha

+2.3569908

MX1

NM_204609

myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse)

+48.569965

NCAM1

NM_001242604

neural cell adhesion molecule 1

-7.5168643

IP6K2

NM_001030596

inositol hexakisphosphate kinase 2

+2.4397569

PML

XM_413690

promyelocytic leukemia

+3.3186321

ZC3H15

NM_001006510

zinc finger CCCH-type containing 15

-2.916313

B2M

NM_001001750

beta-2-microglobulin

+6.515671

PTPN1

L20630

protein tyrosine phosphatase, non-receptor type 1

+3.4228158

PTPN2

NM_001199387

protein tyrosine phosphatase, non-receptor type 2

+2.9723573

CX3CL1

NM_001077232

chemokine (C-X3-C motif) ligand 1

+10.652483

STAT1

NM_001012914

signal transducer and activator of transcription 1, 91 kDa

+12.110944

STAT3

NM_001030931

signal transducer and activator of transcription 3 (acute-phase response factor)

+3.900449

VCAM1

BX950651

vascular cell adhesion molecule 1

-2.8632648

OASL

NM_205041

2′-5′-oligoadenylate synthetase-like

+101.55924

SOCS1

NM_001137648

suppressor of cytokine signaling 1

+15.976115

SOCS3

NM_204600

suppressor of cytokine signaling 3

+30.325502

CD44

NM_204860

CD44 molecule (Indian blood group)

+5.446098

CD74

NM_001001613

CD74 molecule, major histocompatibility complex, class II invariant chain

-7.0005507

Inflammatory response

CDO1

CR353781

cysteine dioxygenase, type I

-6.4660363

CEBPB

NM_205253

CCAAT/enhancer binding protein (C/EBP), beta

+3.5429432

IL23R

XM_422533

interleukin 23 receptor

+3.9536817

EPHX2

NM_001033645

epoxide hydrolase 2, cytoplasmic

-2.0498822

LY96

BX931181

lymphocyte antigen 96

+4.2568717

BLNK

NM_204908

B-cell linker

+3.781344

AOAH

XM_418835

acyloxyacyl hydrolase (neutrophil)

+3.389245

AOX1

NM_001038692

aldehyde oxidase 1

-3.0358417

IGFBP4

NM_204353

insulin-like growth factor binding protein 4

-2.5591307

IL6

NM_204628

interleukin 6 (interferon, beta 2)

+75.02113

IRAK2

NM_001030605

interleukin-1 receptor-associated kinase 2

+2.1085246

KNG1

XM_422766

kininogen 1

-2.1926415

LIPA

AJ719682

lipase A, lysosomal acid, cholesterol esterase (Wolman disease)

+3.7113423

LY75

NM_001037836

lymphocyte antigen 75

+3.9913418

NGFB

M26810

nerve growth factor, beta polypeptide

-2.035398

NOX4

NM_001101829

NADPH oxidase 4

-9.4226265

F11R

NM_001083366

F11 receptor

+4.464096

GAL

NM_001159678

galaninprepropeptide

+8.09671

SERPINA1

BX932103

serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1

-30.80776

S100A9

X61200

S100 calcium binding protein A9

+32.001503

CCL4

NM_001030360

chemokine (C-C motif) ligand 4

+10.783558

CCL17

XM_414018

chemokine (C-C motif) ligand 17

+4.898831

CCL19

BX929857

chemokine (C-C motif) ligand 19

+2.0884924

CCL20

NM_204438

chemokine (C-C motif) ligand 20

+4.089286

BMP2

NM_204358

bone morphogenetic protein 2

+3.6641774

TLR5

CR353090

toll-like receptor 5

-2.4051092

TNFAIP6

NM_001037837

tumor necrosis factor, alpha-induced protein 6

+51.35508

C3

NM_205405

complement component 3

+25.31715

SCG2

BX932277

secretogranin II (chromogranin C)

+3.5667899

ITCH

XM_417330

itchy homolog E3 ubiquitin protein ligase (mouse)

+2.3843937

VNN1

NM_001039288

vanin 1

+30.900112

NMI

BX950337

N-myc (and STAT) interactor

+3.1200686

CHST2

XR_027120

carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2

-2.5672126

HDAC9

CR354257

histone deacetylase 9

-6.544272

Genes were considered significantly up-regulated or down-regulated if the change in their relative expression levels was ≥ 2-fold or ≤ -2-fold.

The DE genes associated with innate immune response, cytokine-mediated signaling pathway, and inflammatory responses were assigned based on GO term. Most genes could also be classified into other categories, but only innate immune response, cytokine-mediated signaling pathway, and inflammatory responses were considered.

+: up-regulated;-: down-regulated.

Validation of microarray data by real-time RT-PCR

Microarray analysis yields a large amount of data; therefore, it is important to validate differential expression by independent methods. Twelve immune and inflammatory response-related genes with significantly altered expression levels during IBV infection were selected for validation by real-time RT-PCR. The data demonstrated that the overall real-time RT-PCR results were consistent with those of the microarray analysis, although several-fold differences were observed between the two analytical methods because of intrinsic differences between the techniques. The real-time RT-PCR results revealed the same relative regulation pattern of transcription as those of the microarray data, thereby validating and confirming the microarray results, which indicated that the expression levels of many genes were significantly changed in response to IBV infection (Table 3).
Table 3

Validation of microarray data by qRT-PCR

Genes

Accession no

Microarray fold change (infected/control)

Real-time RT-PCR fold change (infected/control)

ISG12-2

NM_001001296

+141.21

+197.36

SPP1

NM_204535

+19.54

+3.66

IRG1

NM_001030821

+21.26

+4.28

STAT1

NM_001012914

+16.57

+14.60

TNFAIP6

NM_001037837

+136.96

+3.33

IFITM3

XM_420925

+422.64

+234.00

SOCS3

NM_204600

+24.75

+9.86

IL6

NM_204628

+97.97

+490.15

IFIT5

XM_421662

+130.57

+84.17

RSAD2

XM_426208

+165.91

+193.13

MX1

NM_204609

+91.194

+16.60

OASL

NM_205041

+185.05

+22.07

qRT-PCR results of 12 immune and inflammatory response related genes in kidney tissues from IBV-infected chickens compared to those of control chickens. qRT-PCR levels of RNA for a given gene were normalized against the 18S RNA. “+” indicates up-regulated genes.

Pathway analysis

To further define DE gene function in chicken kidneys after IBV infection, the KEGG database was used to analyze pathways. The results showed that the DE genes were involved in the focal adhesion pathway, cytokine-cytokine receptor interaction pathway, production of cell adhesion molecules, and peroxisome function as well as other pathways involved in host defense responses against IBV infection (Figure 3).
https://static-content.springer.com/image/art%3A10.1186%2F1471-2164-14-743/MediaObjects/12864_2013_Article_5452_Fig3_HTML.jpg
Figure 3

KEGG pathway analysis for differentially expressed genes. The significant pathway for differentially expressed genes. A p-value < 0.05 and FDR < 0.05 were used as a threshold to select significant KEGG pathways. Exact p-value calculation for KEGG pathway analysis in Additional file 2.

STRING analysis of the relationships between DE genes

The STRING database of known and predicted protein interactions was used to predict interactions of the DE genes listed in Table 2 (innate immune response, cytokine-mediated signaling pathway, and inflammatory response-related genes). Figure 4 summarizes the network of predicted associations for DE gene-encoded proteins. The results indicated that genes IL1RL1, IL1R1, IL-1 receptor-associated kinase 2, TLR4, signal transducer and activator of transcription 1 (STAT1), and myeloid differentiation primary response 88 (MYD88) were associated with many signaling pathways and other immune responses, whereas the genes IRF7, IFN-induced protein with tetratricopeptide repeats 1 (IFIT1), myxovirus resistance 1 (MX1), 2′-5′-oligoadenylate synthetase-like (OASL), IFN gamma receptor 1 (IFNGR1), and suppressor of cytokine signaling (SOCS)3 were also related. IL6, STAT1, MYD88, IRF1, and nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (NFKB2) were key in the interaction net and linked to SOCS1, SOCS3, STAT3, IRF1, chemokine (C-C motif) ligand (CCL)17, etc., which were further linked to many downstream genes, indicating that all of these genes were inter-related and formed a large network. However, not all genes were linked, indicating that their functions were either unrelated or have not yet been elucidated.
https://static-content.springer.com/image/art%3A10.1186%2F1471-2164-14-743/MediaObjects/12864_2013_Article_5452_Fig4_HTML.jpg
Figure 4

STRING analysis of the relationship between DE genes related to innate immune response, cytokine-mediated signaling pathways, and inflammatory response related genes. The network nodes represent the proteins encoded by the DE genes. Seven different colored lines link a number of nodes and represent seven types of evidence used in predicting associations. A red line indicates the presence of fusion evidence; a green line represents neighborhood evidence; a blue line represents co-ocurrence evidence; a purple line represents experimental evidence; a yellow line represents text-mining evidence; a light blue line represents database evidence, and a black line represents co-expression evidence.

Discussion

Virulence may differ among IBV strains and, meanwhile, chickens showed various susceptibilities to an IBV strain [17]. To avoid discrepancies, a highly virulent nephropathogenic IBV strain, ck/CH/LDL/091022 [14], was used in this study to infect SPF chickens. Furthermore, fresh kidney tissue samples were collected and used for transcriptome analysis from a chicken infected with ck/CH/LDL/091022 at the time of death. In addition, fresh kidney tissue samples were also collected from of a second chicken infected with ck/CH/LDL/091022 at the time of death, processed individually, and used to confirm the results determined from the first chicken. Only genes that were differentially regulated more than three-fold in both IBV-infected chickens in response to IBV infection were compared to those of control birds and used for further analysis and validation by real-time PCR in this study.

The kidney is a primary target organ of nephropathogenic IBV, in which the transcriptional regulation of host genes after IBV infection can be used as a tool to obtain elaborate insight into virus-host interactions to unravel the pathogenic and/or immune mechanisms of IBV. To our knowledge, this is the first report to use microarray technology to acquire a global profile of host gene expression in chicken kidney cells after IBV infection. Herein, we identified 1777 genes that were differentially regulated more than three-fold compared to the corresponding control group and mostly associated with immune and inflammatory responses. Furthermore, 12 of the immune and inflammatory response DE genes were validated by qRT-PCR. Genes that were differentially expressed during infection can potentially provide insight into the complex regulatory phenomena in response to IBV infection. In our previous study, we identified expression alterations of 53 proteins in kidney tissues of chickens infected with another nephropathogenic IBV strain, ck/CH/LDL/97I, using two-dimensional gel electrophoresis [8, 9]. The shared proteins/genes identified by the two methods were mainly involved in oxidoreductase, receptor binding, and transferase activities, whereas some were associated with immune responses. This might be at least due to the different sampling timepoints and the different virulence of viruses used for infecting chickens. The IBV strain ck/CH/LDL/091022 used in this study is highly nephropathogenic and more virulent than ck/CH/LDL/97I [14]. For Newcastle disease virus, it was reported that the more virulent strain persisted longer in the birds and, therefore, was able to increase the magnitude and duration of cell-mediated immunity [18].

Innate immunity provides a first line of defense against pathogens and can be rapidly activated following infection. Activation of the innate immune system relies on the recognition of pathogen-associated molecular patterns (PAMPs) by specific pattern-recognition receptors (PRRs) [19]. TLR4, TLR5, TLR15, and TLR16 belong to the TLR family and are involved in sensing and initiating immune responses to viral infection [20]. All of the TLRs were significantly up-regulated after IBV infection. Reportedly, severe acute respiratory syndrome (SARS-CoV) and mouse hepatitis virus (MHV) infection can also induce TLR4 expression [21], suggesting that TLR4 possibly has a similar effect both in avian and mammalian species as well as during coronavirus infection. Similar to the present results, a previous study reported that the transcription level of TLR15, a poultry-specific TLR, was significantly up-regulated after infection with Marek’s disease virus [22], infectious bursa disease virus infection [23], and avian influenza virus H9N2-infected chickens in the lungs [24], implicating a similar role of TLR15 in sensing and initiating responses to viruses after infection.

Melanoma differentiation-associated gene-5 (MDA5 or IFIH1) belongs to the retinoic acid-inducible-like helicase family of PRRs and sense viral RNA in the cytoplasm. In this study, MDA5 expression levels were significantly increased after IBV infection. SARS-Cov infection can also induce MDA5 expression in vitro and MHV is recognized by MDA5 in brain macrophages, oligodendrocytes, and microglial cells [2527], suggesting a role of chicken MDA5 against IBV infection and a possible correlation with induction of the inflammatory response.

Although distinct microbial PAMPs activate different TLRs, they ultimately cross paths during the transcriptional activation of IRF3, IRF7, and NF-kB, all of which translocate to the nucleus and activate transcription of type I IFN (IFN-α and IFN-β) [28] and the subsequent IFN-enhanced production of IFN-stimulated genes (ISGs). IBV can induce acute IFN-α production [29] and the ability to induce IFN is linked to the virulence and adaptability of the IBV strain to a particular host system [30, 31]. In this study, IFN expression was not significantly upregulated after IBV infection; however, some IRFs and ISGs, such as IRF1, IRF7, IRF8, IRF10, NF-kB, STAT1, MyD88, OSAL, MX1, IFIT5, ISG12-2, RSAD2, IFI35, and IFI27L2 were all up-regulated. Therefore, we hypothesized that IFN might be induced during early infection, as indicated by the subsequent enhanced production of ISGs because increased expression of a variety of ISGs, such as OSAL, MX1, IFIT5, ISG12-2, RSAD2, IFI35, protein kinase R (PKR), and IFI27L2, was found in this study. STAT proteins form homodimeric and heterodimeric complexes to activate transcription of some ISGs [32]. Similar to the results in the current study, a previous report showed that STAT1 expression was significantly increased response to IBV infection in ovo[10], suggesting that IBV infection can activate the JAK-STAT pathway and activate transcription of ISGs. MX1 is a dynamin-like large guanosinetriphosphatase (GTPase), which has antiviral activity against a wide range of RNA viruses [33]. PKR (also known as EIF2αK2) is constitutively expressed as an inactive kinase that is activated by viral double-stranded RNA and plays an important role in the cellular antiviral response pathway. OASL is a member of the OAS gene family, which in combination with RNaseL constitutes an antiviral RNA decay pathway [34]. The activation of both OAS and PKR results in global degradation of cellular RNA and translation inhibition, which may also inhibit viral propagation [28]. In addition, we found that the MxGTPase pathway, the protein kinase R pathway, and the 2′-5′ oligoadenylate-synthetase-directed ribonuclease L pathway might be involved in anti-IBV infection, but the ISG15 ubiquitin-like pathway was not. These pathways might exert their effects through different mechanisms of action, such as direct targeting of viral entry, inhibition of protein synthesis, or degradation of viral RNA [35], and play an important role in anti-IBV responses and host defense during IBV infection.

Viral infections induce a pro-inflammatory response that include cytokine and chemokine expression [36]. In this study, increased expression of IL6, IL18, IL10RA, IL17RA, CCL4, CCL20, CCL17, and CCL19 was observed after IBV infection; however, chemokine (C-X-C motif) ligand 12 expression was found to be decreased. IL6 was also up-regulated during other nidovirus infections, such as SARS-CoV, porcine respiratory coronavirus, equine arteritis virus, and transmissible gastroenteritis coronavirus (TGEV) [3739]. These findings suggested that IL6, IL18, and IL10 may have similar functions in IBV infection as those in other coronavirus infections. The important negative regulators SOCS-1 and SOCS-3 were significantly up-regulated in this study. SOCS-1 and SOCS-3 participate in the feedback system of IL6 signal transduction by binding to phosphorylated tyrosine residues of a component of the IL6 receptor gp130 [40]. The observed changes in expression of IL6, SOCS-1, and SOCS-3 in kidney tissues of IBV-infected chickens suggested a balance between pro-and anti-inflammatory cytokines, which seemed to be critical for IBV pathogenesis.

Our data also presented an interesting set of apoptosis-related genes after IBV infection. In this study, the expression of the Fas, caspase (casp) 1, casp9, casp18, Bcl-2L1, BCL2-antagonist/killer 1, myeloid cell leukemia sequence 1 (Mcl-1), and eukaryotic initiation factor 2a genes was significantly increased compared to the control group. The caspase proteins are executioners of apoptosis [41]. Extrinsic signals to initiate the apoptotic pathways from receptors (e.g., Fas ligand) culminate in the activation of caspase 8, which activates the effector caspase 3, while intrinsic signaling requires the participation of the mitochondria in releasing cytochrome c to activate caspase 9 for the downstream activation of caspase 3. Both pro-apoptotic (e.g., Bax and Bak) and anti-apoptotic proteins (e.g., Bcl-2 and Bcl-XL) from the Bcl-2 family are key proteins in the intrinsic apoptosis signaling pathway [28]. Recent reports have suggested that IBV also triggers apoptosis during the late stages of its cytolytic infection cycle. Similar results were found in IBV-infected Vero cells at 24 h postinfection, revealing an up-regulation at the transcriptional level of both pro-apoptotic Bak and pro-survival Mcl-1, which may play essential roles in maintaining the intricate balance between life and death of infected cells to ensure a successful infection cycle [42]. Taken together, it can be hypothesized that IBV activates apoptosis through Fas/FasL activation and mitochondrial-dependent pathways, similar to that of TGEV [43, 44]. Furthermore, Bak and Mcl-1 may play key roles in the regulation of IBV-induced apoptosis, not only at an early stage of infection in vitro, but also at a late stage of infection in vivo. In other words, apoptosis is a nonspecific defense mechanism against IBV infection through abortion of viral multiplication by premature lysis of infected cells.

In addition, several other immune function-related genes were up-regulated, including major histocompatibility complex (MHC) class I antigen, MHC BF2 class I, MR1, MHC BF1 class I, immunoresponsive 1 homolog, secreted phosphoprotein 1, the complement system (C3, C1S, C4 and C1R), among other genes involved in the IFR response (IRF1,IRF7,IRF8, IFIH1, IFIT-like ISG12-2, and IFITM3 ). The above results indicated that both adaptive and innate immunity responded to IBV infection and the complement system might be a functional bridge between innate and adaptive immune responses to allow an integrated host defense to pathogenic challenges [45].

The data in this study were obtained from kidney of chickens infected with a nephropathogenic IBV strain at 5 and 6 dpi, respectively, concomitant with the peak of the virus titers in the kidney [14]. The analysis of the global profile of host gene expression provided a good overview of host response to IBV infection and is helpful for understanding IBV mechanism of disease or death. The results also provided basic information needed to extend our understanding of the nature of the virus-host interactions. However, analysis of the innate host immune response in kidneys at those time points may not be sufficient to completely understand IBV immunologic mechanisms. In addition, the roles of individual cell types in this response cannot be effectively measured in this way. Therefore, further analysis of the above-mentioned concerns is warranted. Given the consistent utilization of current vaccines and the continued emergence of new virulent IBV genotypes throughout the world, the development of better vaccines and control strategies will require a greater understanding of pathogenic mechanisms.

Conclusions

We screened and identified differentially expressed transcripts in IBV-infected chicken kidney tissues using microarray analysis. A total of 103 DE genes were identified in this study, which were associated with immune and inflammatory responses, as well as the cytokine-mediated signaling pathway; therefore, these genes may play major roles in the host defense response or/and IBV pathogenesis. Combining network analysis with differential gene expression analysis helped to uncover high-confidence genes, such as IL6, TLR4, STAT1, MYD88, IRF1, and NFKB2, and several immune-related genes, such as IRF7, IFIT1, MX1, OASL, IFNGR1, and SOCS3, that have potentially important consequences to IBV infection. Our results should prove helpful to elucidate the pathogenic mechanisms of IBV and the host antiviral response.

Abbreviations

IBV: 

Infectious bronchitis virus

IB: 

Infectious bronchitis

TLR: 

Toll-like receptors

Mx: 

IFN-induced antiviral genes

SPF: 

Specific pathogen free

Dpi: 

Day post infection

qRT-PCR: 

Quantitative real-time RT-PCR

DE: 

Differential expression

PRRs: 

Pattern recognition receptors

PAMPs: 

Pathogen associated molecular patterns

MHV: 

Mouse hepatitis virus

MDA5: 

Melanoma differentiation-associated gene-5

ISGs: 

IFN-stimulated genes

TGEV: 

Transmissible gastroenteritis coronavirus.

Declarations

Acknowledgements

This work was supported by grants from the China Agriculture Research Systerm (No. CARS-41-K12) and Special Fund for Agro-scientific Research in the Public Interest (No. 201203056).

Authors’ Affiliations

(1)
Division of Avian Infectious Diseases, State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, The Chinese Academy of Agricultural Sciences

References

  1. Carstens E: Report from the 40th meeting of the executive committee of the international committee of taxonomy of viruses. Arch Virol. 2009, 154: 1571-4. 10.1007/s00705-009-0458-x.View ArticleGoogle Scholar
  2. Kinde H, Daft BM, Castro AE, Bickford AA, Gelb J, Reynolds B: Viral pathogenesis of a nephrotropic infectious bronchitis virus isolated from commercial pullets. Avian Dis. 1991, 35: 415-21. 10.2307/1591200.View ArticlePubMedGoogle Scholar
  3. Ahmed Z, Naeem K, Hameed A: Detection and seroprevalence of infectious bronchitis virus strains in commercial poultry in Pakistan. Poult Sci. 2007, 86: 1329-35.View ArticlePubMedGoogle Scholar
  4. Liu S, Kong X: A new genotype of nephropathogenic infectious bronchitis virus circulating in vaccinated and non-vaccinated flocks in China. Avian Pathol. 2004, 33: 321-7. 10.1080/0307945042000220697.View ArticlePubMedGoogle Scholar
  5. Han Z, Sun C, Yan B, Zhang X, Wang Y, Li C, Zhang Q, Ma Y, Shao Y, Liu Q, Kong X, Liu S: A 15-year analysis of molecular epidemiology of avian infectious bronchitis coronavirus in China. Infect Genet Evol. 2011, 11: 190-200. 10.1016/j.meegid.2010.09.002.View ArticlePubMedGoogle Scholar
  6. Mahgoub K, Bassiouni A, Afify MA, Rabie SN: The prevalence of infectious bronchitis (IB) outbreaks in some chicken farms III: cross protection of vaccinated chickens versus field IB virus. J Am Sci. 2010, 6: 94-108.Google Scholar
  7. Schneider RJ, Shenk T: Impact of virus infection on host cell protein synthesis. Annu Rev Biochem. 1987, 56: 317-32. 10.1146/annurev.bi.56.070187.001533.View ArticlePubMedGoogle Scholar
  8. Cao Z, Han Z, Shao Y, Geng H, Kong X, Liu S: Proteomic analysis of chicken embryonic trachea and kidney tissues after infection in ovo by avian infectious bronchitis coronavirus. Proteome Sci. 2011, 9: 11-10.1186/1477-5956-9-11.PubMed CentralView ArticlePubMedGoogle Scholar
  9. Cao Z, Han Z, Shao Y, Liu X, Sun J, Yu D, Kong X, Liu S: Proteomics analysis of differentially expressed proteins in chicken trachea and kidney after infection with the highly virulent and attenuated coronavirus infectious bronchitis virus in vivo. Proteome Sci. 2012, 10: 24-10.1186/1477-5956-10-24.PubMed CentralView ArticlePubMedGoogle Scholar
  10. Dar A, Munir S, Vishwanathan S, Manuja A, Griebel P, Tikoo S, Townsend H, Potter A, Kapur V, Babiuk LA: Transcriptional analysis of avian embryonic tissues following infection with avian infectious bronchitis virus. Virus Res. 2005, 110: 41-55. 10.1016/j.virusres.2005.01.006.View ArticlePubMedGoogle Scholar
  11. Wang X, Rosa AJ, Oliverira HN, Rosa GJ, Guo X, Travnicek M, Girshick T: Transcriptome of local innate and adaptive immunity during early phase of infectious bronchitis viral infection. Viral Immunol. 2006, 19: 768-74. 10.1089/vim.2006.19.768.View ArticlePubMedGoogle Scholar
  12. Emmott E, Rodgers MA, Macdonald A, McCrory S, Ajuh P, Hiscox JA: Quantitative proteomics using stable isotope labeling with amino acids in cell culture reveals changes in the cytoplasmic, nuclear, and nucleolar proteomes in Vero cells infected with the coronavirus infectious bronchitis virus. Mol Cell Proteomics. 2010, 9: 1920-36. 10.1074/mcp.M900345-MCP200.PubMed CentralView ArticlePubMedGoogle Scholar
  13. Emmott E, Smith C, Emmett SR, Dove BK, Hiscox JA: Elucidation of the avian nucleolar proteome by quantitative proteomics using SILAC and changes in cells infected with the coronavirus infectious bronchitis virus. Proteomics. 2010, 10: 3558-62. 10.1002/pmic.201000139.View ArticlePubMedGoogle Scholar
  14. Liu X, Ma H, Xu Q, Sun N, Han Z, Sun C, Guo H, Shao Y, Kong X, Liu S: Characterization of a recombinant coronavirus infectious bronchitis virus with distinct S1 subunits of spike and nucleocapsid genes and a 3′ untranslated region. Vet Microbiol. 2013, 162: 429-36. 10.1016/j.vetmic.2012.10.027.View ArticlePubMedGoogle Scholar
  15. Liu SW, Zhang QX, Chen JD, Han ZX, Liu X, Feng L, Shao YH, Rong JG, Kong XG, Tong GZ: Genetic diversity of avian infectious bronchitis coronavirus strains isolated in China between 1995 and 2004. Arch Virol. 2006, 151: 1133-48. 10.1007/s00705-005-0695-6.View ArticlePubMedGoogle Scholar
  16. Jones R, Ellis R, Cox W, Errington J, Fuller C, Irvine R, Wakeley P: Development and validation of RT‒PCR tests for the detection and S1 genotyping of infectious bronchitis virus and other closely related gammacoronaviruses within clinical samples. Transbound Emerg Dis. 2011, 58: 411-20. 10.1111/j.1865-1682.2011.01222.x.View ArticlePubMedGoogle Scholar
  17. Cavanagh D: Coronavirus avian infectious bronchitis virus. Vet Res. 2007, 38: 281-97. 10.1051/vetres:2006055.View ArticlePubMedGoogle Scholar
  18. Kapczynski DR, Afonso CL, Miller PJ: Immune Responses of Poultry to Newcastle Disease Virus. Dev Comp Immunol. 2013Google Scholar
  19. Girardin SE, Sansonetti PJ, Philpott DJ: Intracellular vs extracellular recognition of pathogens–common concepts in mammals and flies. Trends Microbiol. 2002, 10: 193-9. 10.1016/S0966-842X(02)02334-X.View ArticlePubMedGoogle Scholar
  20. Bowie AG, Haga IR: The role of Toll-like receptors in the host response to viruses. Mol Immunol. 2005, 42: 859-67. 10.1016/j.molimm.2004.11.007.View ArticlePubMedGoogle Scholar
  21. Okabayashi T, Kariwa H, Yokota S, Iki S, Indoh T, Yokosawa N, Takashima I, Tsutsumi H, Fujii N: Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections. J Med Virol. 2006, 78: 417-24. 10.1002/jmv.20556.View ArticlePubMedGoogle Scholar
  22. Smith J, Sadeyen JR, Paton IR, Hocking PM, Salmon N, Fife M, Nair V, Burt DW, Kaiser P: Systems analysis of immune responses in Marek’s disease virus-infected chickens identifies a gene involved in susceptibility and highlights a possible novel pathogenicity mechanism. J Virol. 2011, 85: 11146-58. 10.1128/JVI.05499-11.PubMed CentralView ArticlePubMedGoogle Scholar
  23. Guo X, Wang L, Cui D, Ruan W, Liu F, Li H: Differential expression of the Toll-like receptor pathway and related genes of chicken bursa after experimental infection with infectious bursa disease virus. Arch Virol. 2012, 157: 2189-99. 10.1007/s00705-012-1403-y.View ArticlePubMedGoogle Scholar
  24. Nang NT, Lee JS, Song BM, Kang YM, Kim HS, Seo SH: Induction of inflammatory cytokines and toll-like receptors in chickens infected with avian H9N2 influenza virus. Vet Res. 2011, 42: 64-10.1186/1297-9716-42-64.PubMed CentralView ArticlePubMedGoogle Scholar
  25. Li J, Liu Y, Zhang X: Murine coronavirus induces type I interferon in oligodendrocytes through recognition by RIG-I and MDA5. J Virol. 2010, 84: 6472-82. 10.1128/JVI.00016-10.PubMed CentralView ArticlePubMedGoogle Scholar
  26. Roth-Cross JK, Bender SJ, Weiss SR: Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia. J Virol. 2008, 82: 9829-38. 10.1128/JVI.01199-08.PubMed CentralView ArticlePubMedGoogle Scholar
  27. Yoshikawa T, Hill TE, Yoshikawa N, Popov VL, Galindo CL, Garner HR, Peters CJ, Tseng CT: Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection. PLoS ONE. 2010, 5: e8729-10.1371/journal.pone.0008729.PubMed CentralView ArticlePubMedGoogle Scholar
  28. Zhong Y, Tan YW, Liu DX: Recent progress in studies of arterivirus- and coronavirus-host interactions. Viruses. 2012, 4: 980-1010. 10.3390/v4060980.PubMed CentralView ArticlePubMedGoogle Scholar
  29. Pei J, Sekellick MJ, Marcus PI, Choi IS, Collisson EW: Chicken interferon type I inhibits infectious bronchitis virus replication and associated respiratory illness. J Interferon Cytokine Res. 2001, 21: 1071-7. 10.1089/107999001317205204.View ArticlePubMedGoogle Scholar
  30. Holmes HC, Darbyshire JH: Induction of chicken interferon by avian infectious bronchitis virus. Res Vet Sci. 1978, 25: 178-81.PubMedGoogle Scholar
  31. Otsuki K, Sakagami Y, Tsubokura M: Serological relationship among ten strains of avian infectious bronchitis virus. Acta Virol. 1987, 31: 138-45.PubMedGoogle Scholar
  32. Bovolenta C, Lorini AL, Mantelli B, Camorali L, Novelli F, Biswas P, Poli G: A selective defect of IFN-gamma-but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1. J Immunol. 1999, 162: 323-30.PubMedGoogle Scholar
  33. Haller O, Staeheli P, Kochs G: Interferon-induced Mx proteins in antiviral host defense. Biochimie. 2007, 89: 812-8. 10.1016/j.biochi.2007.04.015.View ArticlePubMedGoogle Scholar
  34. Sadler AJ, Williams BR: Interferon-inducible antiviral effectors. Nat Rev Immunol. 2008, 8: 559-68. 10.1038/nri2314.PubMed CentralView ArticlePubMedGoogle Scholar
  35. Danesh A, Cameron CM, Leon AJ, Ran L, Xu L, Fang Y, Kelvin AA, Rowe T, Chen H, Guan Y, Jonsson CB, Cameron MJ, Kelvin DJ: Early gene expression events in ferrets in response to SARS coronavirus infection versus direct interferon-alpha2b stimulation. Virology. 2011, 409: 102-12. 10.1016/j.virol.2010.10.002.View ArticlePubMedGoogle Scholar
  36. Mogensen TH, Paludan SR: Molecular pathways in virus-induced cytokine production. Microbiol Mol Biol Rev. 2001, 65: 131-50. 10.1128/MMBR.65.1.131-150.2001.PubMed CentralView ArticlePubMedGoogle Scholar
  37. Huang KJ, Su IJ, Theron M, Wu YC, Lai SK, Liu CC, Lei HY: An interferon-gamma-related cytokine storm in SARS patients. J Med Virol. 2005, 75: 185-94. 10.1002/jmv.20255.View ArticlePubMedGoogle Scholar
  38. To KF, Chan PK: Identification of human cell line model of persistent SARS coronavirus infection and studies of the response to cytokines and chemokines. Hong Kong Med. 2009, J15 (Suppl 6): 39-43.Google Scholar
  39. Zhang Y, Li J, Zhan Y, Wu L, Yu X, Zhang W, Ye L, Xu S, Sun R, Wang Y, Lou J: Analysis of serum cytokines in patients with severe acute respiratory syndrome. Infect Immun. 2004, 72: 4410-5. 10.1128/IAI.72.8.4410-4415.2004.PubMed CentralView ArticlePubMedGoogle Scholar
  40. Yasukawa H, Ohishi M, Mori H, Murakami M, Chinen T, Aki D, Hanada T, Takeda K, Akira S, Hoshijima M, Hirano T, Chien KR, Yoshimura A: IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat Immunol. 2003, 4: 551-6. 10.1038/ni938.View ArticlePubMedGoogle Scholar
  41. Cohen GM: Caspases: the executioners of apoptosis. Biochem J. 1997, 326: 1-PubMed CentralView ArticlePubMedGoogle Scholar
  42. Zhong Y, Liao Y, Fang S, Tam JP, Liu DX: Up-regulation of Mcl-1 and Bak by coronavirus infection of human, avian and animal cells modulates apoptosis and viral replication. PLoS ONE. 2012, 7: e30191-10.1371/journal.pone.0030191.PubMed CentralView ArticlePubMedGoogle Scholar
  43. Ding L, Xu X, Huang Y, Li Z, Zhang K, Chen G, Yu G, Wang Z, Li W, Tong D: Transmissible gastroenteritis virus infection induces apoptosis through FasL-and mitochondria-mediated pathways. Veterinary Microbiol. 2012, 158: 12-22. 10.1016/j.vetmic.2012.01.017.View ArticleGoogle Scholar
  44. Marfè G, Tafani M, Fiorito F, Pagnini U, Iovane G, De Martino L: Involvement of FOXO transcription factors, TRAIL-FasL/Fas, and sirtuin proteins family in canine coronavirus type II-induced apoptosis. PLoS ONE. 2011, 6: e27313-10.1371/journal.pone.0027313.PubMed CentralView ArticlePubMedGoogle Scholar
  45. Dunkelberger JR, Song WC: Complement and its role in innate and adaptive immune responses. Cell Res. 2010, 20: 34-50. 10.1038/cr.2009.139.View ArticlePubMedGoogle Scholar

Copyright

© Cong et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.